Malignant tumor of oral cavity (disorder)
PATHOS-T: A bioresource collection associated with PATHOS, a Phase II/III trial of risk-stratified, reduced intensity adjuvant treatment in patients undergoing transoral surgery for human papillomavirus (HPV)-positive oropharyngeal cancer.
Year Started: 2016
Clinical Trial Samples from PATHOS-T (EudraCTnumber: 2014-003392-32)
- Access:
- Closed to access
- Type:
- Clinical Trial
- Status:
- In progress
- Consent restrictions:
-
Other animal work restriction, Xenograft restriction
| Associated Data Type |
Procurement Timeframe |
| There is no associated data for this collection. |
Male
Adult (> 40 years)
11 - 100 donors
| Material Type |
Extraction Procedure |
Storage Temperature |
Preservation Type |
Macroscopic Assessment |
% of Sample Set |
| Serum |
|
-60°C to -85°C |
N/A |
Non-affected |
100% |
Female
Adult (> 40 years)
11 - 100 donors
| Material Type |
Extraction Procedure |
Storage Temperature |
Preservation Type |
Macroscopic Assessment |
% of Sample Set |
| Serum |
|
-60°C to -85°C |
N/A |
Non-affected |
100% |
Male
Adult (> 40 years)
11 - 100 donors
| Material Type |
Extraction Procedure |
Storage Temperature |
Preservation Type |
Macroscopic Assessment |
% of Sample Set |
| Plasma |
|
-60°C to -85°C |
N/A |
Non-affected |
100% |
Female
Adult (> 40 years)
11 - 100 donors
| Material Type |
Extraction Procedure |
Storage Temperature |
Preservation Type |
Macroscopic Assessment |
% of Sample Set |
| Plasma |
|
-60°C to -85°C |
N/A |
Non-affected |
100% |
Male
Adult (> 40 years)
11 - 100 donors
| Material Type |
Extraction Procedure |
Storage Temperature |
Preservation Type |
Macroscopic Assessment |
% of Sample Set |
| Peripheral blood mononuclear cells (PBMC) |
|
Under -85°C |
N/A |
Non-affected |
100% |
Female
Adult (> 40 years)
11 - 100 donors
| Material Type |
Extraction Procedure |
Storage Temperature |
Preservation Type |
Macroscopic Assessment |
% of Sample Set |
| Peripheral blood mononuclear cells (PBMC) |
|
Under -85°C |
N/A |
Non-affected |
100% |
Male
Adult (> 40 years)
11 - 100 donors
| Material Type |
Extraction Procedure |
Storage Temperature |
Preservation Type |
Macroscopic Assessment |
% of Sample Set |
| Tissue specimen |
Surgical procedure (procedure) |
-60°C to -85°C |
N/A |
Affected |
75% -99% |
Female
Adult (> 40 years)
11 - 100 donors
| Material Type |
Extraction Procedure |
Storage Temperature |
Preservation Type |
Macroscopic Assessment |
% of Sample Set |
| Tissue specimen |
Surgical procedure (procedure) |
-60°C to -85°C |
N/A |
Affected |
75% -99% |
Female
Adult (> 40 years)
11 - 100 donors
| Material Type |
Extraction Procedure |
Storage Temperature |
Preservation Type |
Macroscopic Assessment |
% of Sample Set |
| Tissue specimen |
Surgical procedure (procedure) |
RT |
Paraffin |
Affected |
75% -99% |
Male
Adult (> 40 years)
11 - 100 donors
| Material Type |
Extraction Procedure |
Storage Temperature |
Preservation Type |
Macroscopic Assessment |
% of Sample Set |
| Tissue specimen |
Surgical procedure (procedure) |
RT |
Paraffin |
Affected |
75% -99% |
Malignant melanoma of eye (disorder)
SELPAC: A Randomised three-arm, open label, Phase II study of continuous Selumetinib versus continuous or uninterrupted Selumetinib in combination with weekly Paclitaxel in Metastatic Uveal Melanoma.
Year Started: 2015
Clinical Trial Samples from SELPAC clinical trial: samples include plasma and tissue.
- Access:
- Closed to access
- Type:
- Clinical Trial
- Status:
- In progress
- Consent restrictions:
-
No restrictions
| Associated Data Type |
Procurement Timeframe |
| There is no associated data for this collection. |
Female
Adult (> 40 years)
11 - 100 donors
| Material Type |
Extraction Procedure |
Storage Temperature |
Preservation Type |
Macroscopic Assessment |
% of Sample Set |
| Plasma |
|
-60°C to -85°C |
N/A |
Not applicable |
100% |
Male
Adult (> 40 years)
11 - 100 donors
| Material Type |
Extraction Procedure |
Storage Temperature |
Preservation Type |
Macroscopic Assessment |
% of Sample Set |
| Plasma |
|
-60°C to -85°C |
N/A |
Not applicable |
100% |
Female
Adult (> 40 years)
11 - 100 donors
| Material Type |
Extraction Procedure |
Storage Temperature |
Preservation Type |
Macroscopic Assessment |
% of Sample Set |
| Tissue specimen |
Surgical procedure (procedure) |
RT |
Paraffin |
Not applicable |
26 - 50% |
Malignant tumor of pancreas (disorder)
Acelarate: A Phase III, open label, multicentre randomized clinical trial comparing Acelarin (NUC-1031) with Gemcitabine in patient with metastatic pancreatic carcinoma.
Year Started: 2015
Clinical Trial samples from Acelarate clinical trial. Samples include Cell Pellets, Plasma, PK-Plasma, Serum.
- Access:
- Closed to access
- Type:
- Clinical Trial
- Status:
- In progress
- Consent restrictions:
-
Other animal work restriction, Xenograft restriction
| Associated Data Type |
Procurement Timeframe |
| There is no associated data for this collection. |
Female
Adult (> 40 years)
11 - 100 donors
| Material Type |
Extraction Procedure |
Storage Temperature |
Preservation Type |
Macroscopic Assessment |
% of Sample Set |
| Peripheral blood mononuclear cells (PBMC) |
|
Under -85°C |
N/A |
Not applicable |
100% |
Female
Adult (> 40 years)
11 - 100 donors
| Material Type |
Extraction Procedure |
Storage Temperature |
Preservation Type |
Macroscopic Assessment |
% of Sample Set |
| Serum |
|
-60°C to -85°C |
N/A |
Non-affected |
100% |
Female
Adult (> 40 years)
11 - 100 donors
| Material Type |
Extraction Procedure |
Storage Temperature |
Preservation Type |
Macroscopic Assessment |
% of Sample Set |
| Plasma |
|
-60°C to -85°C |
N/A |
Non-affected |
100% |
Male
Adult (> 40 years)
11 - 100 donors
| Material Type |
Extraction Procedure |
Storage Temperature |
Preservation Type |
Macroscopic Assessment |
% of Sample Set |
| Peripheral blood mononuclear cells (PBMC) |
|
Under -85°C |
N/A |
Not applicable |
100% |
Male
Adult (> 40 years)
11 - 100 donors
| Material Type |
Extraction Procedure |
Storage Temperature |
Preservation Type |
Macroscopic Assessment |
% of Sample Set |
| Serum |
|
-60°C to -85°C |
N/A |
Non-affected |
100% |
Male
Adult (> 40 years)
11 - 100 donors
| Material Type |
Extraction Procedure |
Storage Temperature |
Preservation Type |
Macroscopic Assessment |
% of Sample Set |
| Plasma |
|
-60°C to -85°C |
N/A |
Non-affected |
100% |
Malignant tumor of urinary bladder (disorder)
NEOBLADE: Phase II randomised placebo controlled Neoadjuvant chemotherapy study of Nintedanib with Gemcitabine and Cisplatin in locally advanced muscle invasive bladder cancer
Year Started: 2014
Samples from the NEOBLADE clinical trial. Samples include biopsy tissue (FFPE and frozen) and blood (processed to serum, plasma and cells).
- Access:
- Closed to access
- Type:
- Clinical Trial
- Status:
- In progress
- Consent restrictions:
-
Other animal work restriction, Xenograft restriction
| Associated Data Type |
Procurement Timeframe |
| There is no associated data for this collection. |
Male
Adult (> 40 years)
11 - 100 donors
| Material Type |
Extraction Procedure |
Storage Temperature |
Preservation Type |
Macroscopic Assessment |
% of Sample Set |
| Serum |
|
-60°C to -85°C |
N/A |
Non-affected |
100% |
Male
Adult (> 40 years)
11 - 100 donors
| Material Type |
Extraction Procedure |
Storage Temperature |
Preservation Type |
Macroscopic Assessment |
% of Sample Set |
| Plasma |
|
-60°C to -85°C |
N/A |
Non-affected |
100% |
Male
Adult (> 40 years)
11 - 100 donors
| Material Type |
Extraction Procedure |
Storage Temperature |
Preservation Type |
Macroscopic Assessment |
% of Sample Set |
| Peripheral blood mononuclear cells (PBMC) |
|
Under -85°C |
N/A |
Non-affected |
100% |
Male
Adult (> 40 years)
11 - 100 donors
| Material Type |
Extraction Procedure |
Storage Temperature |
Preservation Type |
Macroscopic Assessment |
% of Sample Set |
| Urine |
|
-60°C to -85°C |
N/A |
Not applicable |
100% |
Male
Adult (> 40 years)
11 - 100 donors
| Material Type |
Extraction Procedure |
Storage Temperature |
Preservation Type |
Macroscopic Assessment |
% of Sample Set |
| Tissue specimen |
Surgical procedure (procedure) |
Under -85°C |
N/A |
Not applicable |
51 - 75% |
Malignant tumor of pancreas (disorder)
PanASTA: Cattell Warren versus Blumgart techniques of pancreatico-jejunostomy following pacreato-duodenectomy – a double blinded multi-centred trial (Phase III).
Year Started: 2015
Clinical trial samples from the PANasta trial.
- Access:
- Closed to access
- Type:
- Clinical Trial
- Status:
- In progress
- Consent restrictions:
-
Other animal work restriction, Xenograft restriction
| Associated Data Type |
Procurement Timeframe |
| There is no associated data for this collection. |
Female
Adult (> 40 years)
11 - 100 donors
| Material Type |
Extraction Procedure |
Storage Temperature |
Preservation Type |
Macroscopic Assessment |
% of Sample Set |
| Peripheral blood mononuclear cells (PBMC) |
|
Under -85°C |
N/A |
Non-affected |
100% |
Female
Adult (> 40 years)
11 - 100 donors
| Material Type |
Extraction Procedure |
Storage Temperature |
Preservation Type |
Macroscopic Assessment |
% of Sample Set |
| Serum |
|
-60°C to -85°C |
N/A |
Non-affected |
100% |
Female
Adult (> 40 years)
11 - 100 donors
| Material Type |
Extraction Procedure |
Storage Temperature |
Preservation Type |
Macroscopic Assessment |
% of Sample Set |
| Plasma |
|
-60°C to -85°C |
N/A |
Non-affected |
100% |
Female
Adult (> 40 years)
11 - 100 donors
| Material Type |
Extraction Procedure |
Storage Temperature |
Preservation Type |
Macroscopic Assessment |
% of Sample Set |
| Tissue specimen |
Surgical procedure (procedure) |
RT |
Paraffin |
Affected |
11 - 25% |
Male
Adult (> 40 years)
11 - 100 donors
| Material Type |
Extraction Procedure |
Storage Temperature |
Preservation Type |
Macroscopic Assessment |
% of Sample Set |
| Peripheral blood mononuclear cells (PBMC) |
|
Under -85°C |
N/A |
Non-affected |
100% |
Male
Adult (> 40 years)
11 - 100 donors
| Material Type |
Extraction Procedure |
Storage Temperature |
Preservation Type |
Macroscopic Assessment |
% of Sample Set |
| Serum |
|
-60°C to -85°C |
N/A |
Non-affected |
100% |
Male
Adult (> 40 years)
11 - 100 donors
| Material Type |
Extraction Procedure |
Storage Temperature |
Preservation Type |
Macroscopic Assessment |
% of Sample Set |
| Plasma |
|
-60°C to -85°C |
N/A |
Non-affected |
100% |
Male
Adult (> 40 years)
11 - 100 donors
| Material Type |
Extraction Procedure |
Storage Temperature |
Preservation Type |
Macroscopic Assessment |
% of Sample Set |
| Tissue specimen |
Surgical procedure (procedure) |
RT |
Paraffin |
Affected |
11 - 25% |
Malignant tumor of pancreas (disorder)
ViP - A prospective, phase II, double blinded, multicentre, randomised clinical trial comparing combination gemcitabine and Vandetanib therapy with gemcitabine therapy alone in locally advanced or metastatic pancreatic carcinoma.
Year Started: 2011
Clinical trial samples from the ViP study. Samples include blood (serum, plasma and cell pellet) and tissue (FFPE).
- Access:
- Closed to access
- Type:
- Clinical Trial
- Status:
- Completed
- Consent restrictions:
-
Other animal work restriction, Xenograft restriction
| Associated Data Type |
Procurement Timeframe |
| There is no associated data for this collection. |
Male
Adult (> 40 years)
11 - 100 donors
| Material Type |
Extraction Procedure |
Storage Temperature |
Preservation Type |
Macroscopic Assessment |
% of Sample Set |
| Peripheral blood mononuclear cells (PBMC) |
|
-60°C to -85°C |
N/A |
Non-affected |
75% -99% |
Male
Adult (> 40 years)
11 - 100 donors
| Material Type |
Extraction Procedure |
Storage Temperature |
Preservation Type |
Macroscopic Assessment |
% of Sample Set |
| Serum |
|
-60°C to -85°C |
N/A |
Non-affected |
75% -99% |
Male
Adult (> 40 years)
11 - 100 donors
| Material Type |
Extraction Procedure |
Storage Temperature |
Preservation Type |
Macroscopic Assessment |
% of Sample Set |
| Plasma |
|
-60°C to -85°C |
N/A |
Non-affected |
75% -99% |
Male
Adult (> 40 years)
11 - 100 donors
| Material Type |
Extraction Procedure |
Storage Temperature |
Preservation Type |
Macroscopic Assessment |
% of Sample Set |
| Tissue specimen |
Surgical procedure (procedure) |
RT |
Paraffin |
Affected |
11 - 25% |
Female
Adult (> 40 years)
11 - 100 donors
| Material Type |
Extraction Procedure |
Storage Temperature |
Preservation Type |
Macroscopic Assessment |
% of Sample Set |
| Peripheral blood mononuclear cells (PBMC) |
|
-60°C to -85°C |
N/A |
Non-affected |
75% -99% |
Female
Adult (> 40 years)
11 - 100 donors
| Material Type |
Extraction Procedure |
Storage Temperature |
Preservation Type |
Macroscopic Assessment |
% of Sample Set |
| Serum |
|
-60°C to -85°C |
N/A |
Non-affected |
75% -99% |
Female
Adult (> 40 years)
11 - 100 donors
| Material Type |
Extraction Procedure |
Storage Temperature |
Preservation Type |
Macroscopic Assessment |
% of Sample Set |
| Plasma |
|
-60°C to -85°C |
N/A |
Non-affected |
75% -99% |
Female
Adult (> 40 years)
11 - 100 donors
| Material Type |
Extraction Procedure |
Storage Temperature |
Preservation Type |
Macroscopic Assessment |
% of Sample Set |
| Tissue specimen |
Surgical procedure (procedure) |
RT |
Paraffin |
Affected |
11 - 25% |
Osteoradionecrosis (disorder)
HOPON (Hyperbaric Oxygen for the Prevention of Osteoradionecrosis): A Randomised Controlled Trial of Hyperbaric Oxygen to prevent Osteoradionecrosis of the Irradiated Mandible.
Year Started: 2008
Clinical Trial samples from HOPON clinical trial. Samples include Cell Pellets and Plasma.
- Access:
- Closed to access
- Type:
- Clinical Trial
- Status:
- In progress
- Consent restrictions:
-
Other animal work restriction, Xenograft restriction
| Associated Data Type |
Procurement Timeframe |
| There is no associated data for this collection. |
Male
Adult (> 40 years)
11 - 100 donors
| Material Type |
Extraction Procedure |
Storage Temperature |
Preservation Type |
Macroscopic Assessment |
% of Sample Set |
| Plasma |
|
-60°C to -85°C |
N/A |
Non-affected |
100% |
Male
Adult (> 40 years)
11 - 100 donors
| Material Type |
Extraction Procedure |
Storage Temperature |
Preservation Type |
Macroscopic Assessment |
% of Sample Set |
| Peripheral blood mononuclear cells (PBMC) |
|
-60°C to -85°C |
N/A |
Non-affected |
100% |
Female
Adult (> 40 years)
11 - 100 donors
| Material Type |
Extraction Procedure |
Storage Temperature |
Preservation Type |
Macroscopic Assessment |
% of Sample Set |
| Peripheral blood mononuclear cells (PBMC) |
|
-60°C to -85°C |
N/A |
Non-affected |
100% |
Female
Adult (> 40 years)
11 - 100 donors
| Material Type |
Extraction Procedure |
Storage Temperature |
Preservation Type |
Macroscopic Assessment |
% of Sample Set |
| Plasma |
|
-60°C to -85°C |
N/A |
Non-affected |
100% |